Redefining accessible
Genomill Health is a precision diagnostics company with a mission to disrupt the use of molecular diagnostic tests – liquid biopsies and beyond. We want to harness the use of the Next-Generation-Sequencing in diagnostics to the next level with our novel patent-pending Geno1™ pre-sequencing technology, enabling unprecedented improvements in performance and scalability.
Reduced
cost
Increased
accuracy
Faster
turn-around-time
Geno1™
Driven by world-class research
Our Geno1™ technology is a unique combination of molecular biology, robotics, next-generation DNA sequencing and artificial intelligence.
It truly provides means for unprecedented scaling of liquid biopsies and beyond by tackling the three main drivers: cost, accuracy and turn-around-time.
Join our journey
We’re set to saturate the scattered liquid biopsy space with our technology. We offer Geno1™ for out-licensing and are continuously looking for new long-term partnerships within oncology and other verticals – such as tropical and infectious diseases, NIPT, antibiotic resistance.
Join us in harnessing a true game-changing technology!
Get in touch by emailing us at info@genomill.com!
Latest news
Genomeweb: Genomill Health Positioning Geno1 Technology to Improve Liquid Biopsy Sequencing
